ATE297920T1 - Linezolid-krystall form ii - Google Patents

Linezolid-krystall form ii

Info

Publication number
ATE297920T1
ATE297920T1 AT01904805T AT01904805T ATE297920T1 AT E297920 T1 ATE297920 T1 AT E297920T1 AT 01904805 T AT01904805 T AT 01904805T AT 01904805 T AT01904805 T AT 01904805T AT E297920 T1 ATE297920 T1 AT E297920T1
Authority
AT
Austria
Prior art keywords
linezolide
crystal form
crystal
linezolide crystal
Prior art date
Application number
AT01904805T
Other languages
English (en)
Inventor
Michael S Bergren
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE297920(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Application granted granted Critical
Publication of ATE297920T1 publication Critical patent/ATE297920T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01904805T 2000-02-02 2001-01-29 Linezolid-krystall form ii ATE297920T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17983700P 2000-02-02 2000-02-02
PCT/US2001/000657 WO2001057035A1 (en) 2000-02-02 2001-01-29 Linezolid-crystal form ii

Publications (1)

Publication Number Publication Date
ATE297920T1 true ATE297920T1 (de) 2005-07-15

Family

ID=22658183

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01904805T ATE297920T1 (de) 2000-02-02 2001-01-29 Linezolid-krystall form ii

Country Status (31)

Country Link
EP (1) EP1255754B1 (de)
JP (1) JP5235256B2 (de)
KR (3) KR20080044358A (de)
CN (1) CN1221547C (de)
AR (1) AR027261A1 (de)
AT (1) ATE297920T1 (de)
AU (1) AU782138B2 (de)
BR (1) BR0107667A (de)
CA (1) CA2395603C (de)
CO (1) CO5261555A1 (de)
CZ (1) CZ302292B6 (de)
DE (1) DE60111497T2 (de)
DK (1) DK1255754T3 (de)
EA (1) EA004434B1 (de)
EE (1) EE05197B1 (de)
ES (1) ES2242728T3 (de)
HK (1) HK1051196A1 (de)
HU (1) HUP0301076A3 (de)
IL (1) IL151010A0 (de)
MX (1) MXPA02007471A (de)
MY (1) MY122829A (de)
NO (2) NO323459B1 (de)
NZ (1) NZ520541A (de)
PE (1) PE20011086A1 (de)
PL (1) PL356433A1 (de)
PT (1) PT1255754E (de)
SI (1) SI1255754T1 (de)
SK (1) SK287025B6 (de)
TW (1) TWI297687B (de)
WO (1) WO2001057035A1 (de)
ZA (1) ZA200205162B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100490643B1 (ko) * 2002-10-29 2005-05-19 한국과학기술연구원 새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
DK1673370T3 (da) 2003-10-16 2009-12-07 Symed Labs Ltd Krystallingsk form af linezolid
WO2005099353A2 (en) 2004-04-19 2005-10-27 Symed Labs Limited A novel process for the preparation of linezolid and related compounds
EP2174935A1 (de) * 2004-06-29 2010-04-14 Teva Pharmaceutical Industries Ltd Linezolidzusammensetzungen
MX2007000084A (es) * 2004-06-29 2007-06-14 Teva Pharma Formas solidas de linezolid y procesos para la preparacion delas mismas.
US7291614B2 (en) * 2005-02-24 2007-11-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
EP1893195A2 (de) * 2005-06-22 2008-03-05 Teva Pharmaceutical Industries Ltd Polymorphe formen von tegaserodmaleat
EP1749517B8 (de) * 2005-07-20 2008-10-22 Teva Pharmaceutical Industries Ltd. Stabile pharmazeutische Zusammensetzung mit Linezolid Form IV
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
EP2099299A4 (de) * 2006-10-23 2011-11-30 Concert Pharmaceuticals Inc Oxazolidinon-derivate und verfahren zu ihrer verwendung
WO2011050826A1 (en) 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
EP2563781B1 (de) 2010-04-30 2016-10-26 Indiana University Research and Technology Corporation Verfahren zur herstellung von linezolid
EP2603506A1 (de) 2010-08-11 2013-06-19 Synthon BV Verfahren zur herstellung von linezolid
WO2012019632A1 (en) 2010-08-11 2012-02-16 Synthon B.V. Process for making linezolid
EP2593440A1 (de) * 2011-02-24 2013-05-22 Lee Pharma Limited Kristalline form ii von wasserfreiem linezolid
EP2683696A1 (de) 2011-03-09 2014-01-15 Synthon BV Verfahren zur herstellung einer kristallinen form von linezolid
CN102731341A (zh) * 2011-04-13 2012-10-17 上海医药工业研究院 用于制备利奈唑胺的中间体及其制备方法
CN102766106A (zh) * 2011-05-03 2012-11-07 江苏豪森医药集团有限公司 利奈唑胺的新晶型及其制备方法
CN102399200B (zh) * 2011-12-14 2013-12-04 浙江新东港药业股份有限公司 一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
IN2014DN06213A (de) 2012-01-24 2015-10-23 Jubilant Life Sciences Ltd
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) * 2012-04-10 2012-08-22 杭州华东医药集团生物工程研究所有限公司 一种利奈唑胺晶型及其制备方法
WO2014071990A1 (en) 2012-11-09 2014-05-15 Synthon Bv Process for making linezolid
SG11202003537TA (en) * 2017-11-16 2020-05-28 Persica Pharmaceuticals Ltd Linezolid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
CZ200788A3 (cs) * 1996-04-11 2017-01-25 Pfizer Inc. Způsob přípravy 5-aminomethyl substituovaných oxazolidinonaminů
JP2001522828A (ja) * 1997-11-07 2001-11-20 ファルマシア・アンド・アップジョン・カンパニー オキサゾリジノンの製法

Also Published As

Publication number Publication date
NO323459B1 (no) 2007-05-14
KR20070087178A (ko) 2007-08-27
AR027261A1 (es) 2003-03-19
EA004434B1 (ru) 2004-04-29
EE05197B1 (et) 2009-08-17
MXPA02007471A (es) 2002-12-13
CA2395603C (en) 2010-03-23
KR20080044358A (ko) 2008-05-20
MY122829A (en) 2006-05-31
NO20023654D0 (no) 2002-08-01
CN1394207A (zh) 2003-01-29
WO2001057035A1 (en) 2001-08-09
EP1255754A1 (de) 2002-11-13
CO5261555A1 (es) 2003-03-31
DK1255754T3 (da) 2005-08-22
SK287025B6 (sk) 2009-10-07
DE60111497T2 (de) 2006-05-18
NO20023654L (no) 2002-08-01
ZA200205162B (en) 2003-09-29
CZ20022635A3 (cs) 2002-10-16
KR20020072300A (ko) 2002-09-14
HK1051196A1 (en) 2003-07-25
PE20011086A1 (es) 2001-10-04
CA2395603A1 (en) 2001-08-09
SI1255754T1 (sl) 2005-12-31
IL151010A0 (en) 2003-02-12
EA200200819A1 (ru) 2003-02-27
EP1255754B1 (de) 2005-06-15
CN1221547C (zh) 2005-10-05
AU3275501A (en) 2001-08-14
NZ520541A (en) 2004-02-27
TWI297687B (en) 2008-06-11
PL356433A1 (en) 2004-06-28
HUP0301076A2 (hu) 2003-08-28
AU782138B2 (en) 2005-07-07
JP2003522175A (ja) 2003-07-22
SK9942002A3 (en) 2002-11-06
ES2242728T3 (es) 2005-11-16
HUP0301076A3 (en) 2004-06-28
CZ302292B6 (cs) 2011-02-09
BR0107667A (pt) 2002-10-08
KR100864745B1 (ko) 2008-10-22
DE60111497D1 (de) 2005-07-21
JP5235256B2 (ja) 2013-07-10
PT1255754E (pt) 2005-11-30
NO20065836L (no) 2002-08-01
EE200200420A (et) 2003-12-15
KR100781815B1 (ko) 2007-12-03

Similar Documents

Publication Publication Date Title
ATE297920T1 (de) Linezolid-krystall form ii
DE60129488D1 (de) Anzeigegerät
DE60140253D1 (de) Oreinheit
DE60131369D1 (de) Luminizenzglucosemessung
NO20032245D0 (no) Brönnbehandling
NO20032243L (no) Brönnbehandlingsmetode
DE60138166D1 (de) dlosfilamenten
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
NO20030276L (no) Fremgangsmåte
FR2810866B1 (fr) Presentoir
AR028336A1 (es) 4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE60142401D1 (de) Verbindungsverfahren
AR027931A1 (es) Antitranspirantes
AR027982A1 (es) Aril- y heteroarilsulfonatos
DE60114278D1 (de) Kalenderuhr
DE50109358D1 (de) Flüssigkristall-Anzeige
DE10195992T1 (de) Oberflächenendbearbeitungsbelag
NO20031215L (no) Difosfonatlösninger
FIU20000076U0 (fi) Kalanteri
FI20000399A0 (fi) Kalanteri
AT500246B8 (de) Chokerring
DE60038936D1 (de) Einkristallziehvorrichtung
FI4742U1 (fi) Kalanteri
DE50105745D1 (de) Anzeigeeinrichtung
DE50101594D1 (de) Sekundärluftzuführeinheit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1255754

Country of ref document: EP